In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the recent FDA approvals of Leqembi and Opill, a price transparency and PBM reform package working its way through Congress, and the recent series C funding raise for Octave.
Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, CMS, DA, Medicare, drug prices, PBM, Alzheimer’s, women’s health, reproductive health, mental health, telemedicine, virtual care
Source Links:
- New Federal Decisions Make Alzheimer’s Drug Leqembi Widely Accessible
- With nonprescription nod for Perrigo’s Opill, the age of the over-the-counter birth control pill arrives in the US
- House committee moves another price transparency, PBM reform package forward
- Education and the Workforce Committee Passes Landmark Health Care Package
- Octave nabs $52M, eyes expansion of in-network therapy services to all 50 states in 2024
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor and Head of Public Health Sector
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Director
Listen now
Speed to publication with GenAI: Done the right way
In the last three years, Generative AI (GenAI) has moved from novelty to expectation. Across industries, teams are being asked, whether explicitly or
Read moreInizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read moreASH® 2025 roundtable: Turning hematology innovation into real world progress
Insights from ASH® 2025 on hematology innovation, CAR-T, bispecifics, diagnostics, and how connected strategy supports real-world adoption.
Read more